re: sales of relenza fianlly found confirmation re sales of relenza over the quarter
http://www.bloomberg.com/apps/news?pid=10000085&sid=aS1YwybiZb.c&refer=europe
"Glaxo said sales of Relenza rose 70 percent to 5.2 million pounds. "
That is, about 12.27 million Aus dollars, or at royalties of 7% about $860,000 to Biota.
But only for a quarter and off a very low base of production.
- Forums
- ASX - By Stock
- BTA
- gsk downplaying news
gsk downplaying news, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online